So far, I haven't heard of Leronlimab having any contraindications with other drugs. In the case of inflammatory cytokines, Leronlimab should make and excellent additional treatment. If Leronlimab hasn't been used with either a particular treatment or combination of treatments, initial use should be cautionary (possible lower dose to start). Inflammatory cytokines are an issue with almost any trauma. I don't think it is far fetched to think that Leronlimab should be present in every emergency facility and with first responders (that includes the battlefield).
But first, our team needs to get that first approval!
This is only my opinion. GLTUA